NewsBenzingaL’icotrokinra chlorhydrate de Johnson & Johnson reçoit l’approbation de la Medicines and Healthcare Products Regulatory Agency pour traiter le psoriasis en plaques modéré à sévère L’icotrokinra chlorhydrate de Johnson & Johnson reçoit l’approbation de la Medicines and Healthcare Products Regulatory Agency pour traiter le psoriasis en plaques modéré à sévère Benzinga 2026.10.23 14:27 (GMT+0) Open on Benzinga Other news Nvidia Shares Rise After Earnings Beat in First Report Since Jensen Huang's Exit NVIDIA Chairman Harvey Jones: Board Has No Intention of Restoring Jensen Huang as CEO Slower Retail Sales Drag on Market SEC reportedly investigating Nvidia amid Huang exit A $3 Billion Reason Why Disney Stock Is in Focus Today Google joins the tech outage trend by announcing it’s not having one